ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $416,392 | -61.3% | 11,680 | -49.9% | 0.10% | -60.9% |
Q2 2023 | $1,074,829 | +23.2% | 23,300 | +7.1% | 0.27% | +26.1% |
Q1 2023 | $872,175 | -13.4% | 21,750 | 0.0% | 0.21% | -13.5% |
Q4 2022 | $1,007,678 | +6.5% | 21,750 | -4.8% | 0.24% | +8.4% |
Q3 2022 | $946,000 | +1.9% | 22,840 | +46.9% | 0.22% | +3.2% |
Q2 2022 | $928,000 | -17.8% | 15,550 | 0.0% | 0.22% | -46.2% |
Q1 2022 | $1,129,000 | -13.7% | 15,550 | 0.0% | 0.40% | +45.7% |
Q4 2021 | $1,308,000 | +20.0% | 15,550 | +28.6% | 0.28% | -15.0% |
Q3 2021 | $1,090,000 | +62.0% | 12,090 | +71.1% | 0.33% | +69.4% |
Q2 2021 | $673,000 | +2.6% | 7,065 | +22.5% | 0.19% | -13.5% |
Q1 2021 | $656,000 | +42.9% | 5,765 | +73.6% | 0.22% | +50.7% |
Q4 2020 | $459,000 | -51.2% | 3,320 | -71.0% | 0.15% | -48.1% |
Q3 2020 | $941,000 | -27.2% | 11,450 | -30.7% | 0.28% | -22.3% |
Q2 2020 | $1,292,000 | +98.2% | 16,515 | +12.6% | 0.37% | +54.2% |
Q1 2020 | $652,000 | +4.2% | 14,665 | 0.0% | 0.24% | -4.0% |
Q4 2019 | $626,000 | +13.2% | 14,665 | +13.5% | 0.25% | +15.9% |
Q3 2019 | $553,000 | -16.0% | 12,925 | +24.7% | 0.21% | -23.3% |
Q2 2019 | $658,000 | -8.5% | 10,365 | 0.0% | 0.28% | -15.7% |
Q1 2019 | $719,000 | +126.1% | 10,365 | +41.7% | 0.33% | +105.6% |
Q4 2018 | $318,000 | -40.9% | 7,315 | +3.8% | 0.16% | -31.2% |
Q3 2018 | $538,000 | +20.6% | 7,045 | +21.5% | 0.23% | +11.4% |
Q2 2018 | $446,000 | – | 5,800 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 38,100 | $2,928,000 | 1.67% |
Opaleye Management Inc. | 80,000 | $6,149,000 | 1.59% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 410,000 | $31,517,000 | 1.06% |
Opus Point Partners Management, LLC | 6,311 | $485,000 | 1.05% |
SECTOR GAMMA AS | 68,015 | $5,228,000 | 0.87% |
Capital Impact Advisors, LLC | 27,074 | $2,061,000 | 0.76% |
FORTALEZA ASSET MANAGEMENT INC/ | 1,130 | $87,000 | 0.71% |
CAPITAL INTERNATIONAL LTD /CA/ | 46,957 | $3,610,000 | 0.63% |
Virtus ETF Advisers LLC | 8,794 | $676,000 | 0.60% |
Rock Springs Capital Management LP | 200,000 | $15,374,000 | 0.59% |